International Pandemic Preparedness Secretariat

📣 At this year’s Munich Security Conference, CEPI spotlighted how we are working towards the #100DaysMission to prepare for future epidemic and pandemic threats - however and wherever they may occur. With biosecurity and biosafety essential to achieving this goal safely and securely, CEPI, Brown University Pandemic Center and Nuclear Threat Initiative, in partnership with Foreign Policy, hosted 'Mission Possible! Fast-tracking biosecurity and the 100 Days Mission roundtable with next-generation leaders across the Global South'. The inspiring discussion culminated in the creation of a new declaration, issued by a group of Global South Biosecurity Game Changers. It calls on global partners to urgently accelerate actions to ensure biosafety and biosecurity are integral components of the 100 Days Mission and of the global life science research and biotechnology sectors: https://lnkd.in/epg8GzgN CEPI's Chair Jane Halton AO PSM FAICD, said: "Current and future leaders, including from the Global South, must grapple with the pace of emerging technologies and the sheer multitude of emergencies like H5N1, Ebola, and Marburg to find solutions that can be driven and implemented across generations and geographies in support of the bold ambition to take biological threats off the table.” CEPI Director of Biosecurity, Andrew Hebbeler, also participated in the ‘Protecting the World from Pathogens: Biosecurity in the age of transformational tech' panel discussion as part of Foreign Policy’s Emerging Threats forum. The CEPI Team joined a number of other events and discussions highlighting the links between climate change and health security, safeguarding emerging technologies, and the need for collaboration between the health and security sectors to protect society from infectious disease threats. Discover more: https://lnkd.in/epg8GzgN

🌐 The latest implementation report for the 100 Days Mission report offers a comprehensive assessment of how ready the world is to respond to another pandemic. Explore the report's key findings, scorecard, and priority actions for 2025: bit.ly/100DM-4thReport International Pandemic Preparedness Secretariat

🔊 "This report not only gives us the inspiration of the progress madem, but shows the partnerships that are converging to address critical issues that will allow us to respond within 100 days of a pandemic [threat]." Watch below as Dr Petro Terblanche, CEO of Afrigen Biologics (Pty) Ltd, reacting to the launch of the #100DaysMission 4th Implementation Report and underlining the progress made through African leadership on pandemic preparedness in 2024. ➡️ Read the report here: https://lnkd.in/eWmXmhyY #PandemicPreparedness

At the recent launch of the #100DaysMission 4th Implementation Report, IPPS Chair and Canada's Chief Science Adviser Dr Mona Nemer highlighted the urgent need for global pandemic preparedness. Her powerful message reminds us that proactive investment in research and development is not optional. Read the report to learn more about the status of R&D for diagnostics, therapeutics and vaccines. ➡️ https://lnkd.in/e5Ua4W7f

The INTREPID Alliance is proud to support the International Pandemic Preparedness Secretariat in the launch of the 100 Days Mission 4th Implementation Report—a key assessment of global progress toward faster, more effective pandemic responses. This report, developed with input from 50 global partners, represents a collaborative commitment to ensuring the world is better prepared for future health threats. We stand with you in highlighting the importance of global collaboration to advance the antiviral clinical pipeline—a priority emphasized in the #100DaysMission and INTREPID’s AntiviralClinicalDevelopmentLandscape. Read the news  ➡️ https://lnkd.in/dg3iyGyW #PandemicPreparedness

🔊 '[The report highlights] the very thin pipeline we have in the therapeutics space, the effort to build the therapeutics coalition is a tremendous accomplishment' Watch below as Prof Kelly Chibale, speaking at the launch of the #100DaysMission 4th Implementation Report, underlines the importance of developing therapeutics through to phase two trials and strengthening capacity in LMICs to participate in local innovation for pandemic preparedness. ➡️ Read the report here: https://lnkd.in/e5Ua4W7f INTREPID Alliance ┃ #PandemicPreparedness

🌍 𝗚𝗹𝗼𝗣𝗜𝗗-𝗥’𝘀 𝗪𝗼𝗿𝗸 𝗙𝗲𝗮𝘁𝘂𝗿𝗲𝗱 𝗶𝗻 𝘁𝗵𝗲 𝗟𝗮𝘁𝗲𝘀𝘁 𝗜𝗣𝗣𝗦 𝗥𝗲𝗽𝗼𝗿𝘁 📄 The International Pandemic Preparedness Secretariat (IPPS) launched its fourth implementation report on January 31, 2025, during an event co-hosted with the South African Department of Health and SAMRC in Cape Town. Accompanied by the second 100DM scorecard, the report highlights ongoing gaps, particularly in diagnostics and therapeutics development. 💊 👉🏻 the report showcases GloPID-R’s contributions, including Pandemic PACT and the GloPID-R Funders Living Roadmap for Clinical Trial Coordination. Additionally, GloPID-R’s Africa Hub has contributed to the 100-Day Mission's progress. 📌 𝗥𝗲𝗮𝗱 𝗠𝗼𝗿𝗲: https://lnkd.in/estszSJV #Research #GloPIDR #PandemicPACT #IPPS

Recently, the 100 Days Mission report (2024) was launched in Cape Town, South Africa. The 100 Days Mission’s goal is to ensure diagnostics, therapeutics, and vaccines are available within 100 days of the declaration of a Public Health Emergency of International Concern (PHEIC). #WHOAFRO’s Dr Miriam Nanyunja shared insights on key preparedness actions for achieving this in Africa, including: ✅ Strengthening surveillance systems, including genomic surveillance ✅ Increasing national and global investment in research, development, and clinical trial readiness, including pre-approved protocols ✅ Strengthening leadership and collaboration

🌍 Impressive progress in #Uganda's response to the ongoing outbreak of Sudan ebolavirus. Vaccinations are underway as part of a World Health Organization-led trial taking place at Makerere University Lung Institute in Kampala, using a vaccine candidate from IAVI. IPPS recently published the #100DaysMission Scorecard 2.0, developed with Impact Global Health, which outlines the status of available medical countermeasures for priority pathogens, including Ebola. ➡️ Learn more: https://lnkd.in/eWmXmhyY

🗞 BREAKING: Africa’s leading National Regulatory Authorities have signed a landmark MoU to harmonize health regulations and accelerate access to life-saving medical products. Regulatory agencies from Ghana, South Africa, Tanzania, Nigeria, Zimbabwe, Senegal, and Rwanda—all World Health Organization Maturity Level 3-certified—are joining forces to streamline processes, enhance efficiency, and strengthen local manufacturing. This MoU, facilitated by Africa CDC, African Union Development Agency-NEPAD, and the African Medicines Regulatory Harmonization (AMRH) initiative, marks a critical step toward self-reliance in medical product manufacturing. This partnership is more than an agreement—it’s a commitment to an Africa-led future where regulatory excellence ensures equitable, timely access to quality medicines and vaccines. See more: https://ow.ly/LIcH50UUe5N #AfricaCDC #HealthforAll